Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose atorvastatin in traumatic brain injury
IRCT20250803066738N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin in traumatic brain injury (TBI) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Fibrinogen levels and White blood cell count. Started Aug 2025; status: completed.
02
Drugs
atorvastatin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20250803066738N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250803066738N1.